Home treatment in patients with antibody deficiency by slow subcutaneous infusion of gammaglobulin
Roord, J.J.; van der Meer, J.W.; Kuis, W.; de Windt, G.E.; Zegers, B.J.; van Furth, R.; Stoop, J.W.
Lancet 1(8273): 689-690
1982
ISSN/ISBN: 0140-6736 PMID: 6175862 Document Number: 195402
Document emailed within 1 workday
Related Documents
Roord, J.J.; van der Meer, J.W.; Kuis, W.; van Furth, R. 1983: Treatment of antibody deficiency syndromes with subcutaneous infusion of gamma globulin Birth Defects Original Article Series 19(3): 217-221Frankel, S.J.; Polmar, S.H.; Grumet, F.C.; Wedner, H.J. 1986: Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin Annals of Allergy 56(5): 436-439
Effersøe, H.; Andersen, V. 1985: Subcutaneous infusion of IgG in patients with hypogammaglobulinemia Ugeskrift for Laeger 147(42): 3303-3305
Albani, C.; Zangger, I.; Fischer, G. 1992: Subcutaneous apomorphine infusion in the treatment of Parkinson disease Schweizerische Rundschau für Medizin Praxis 81(35): 1011-1015
Grandas, F.J.; Sesar-Ignacio, Án. 2012: Subcutaneous continuous apomorphine infusion: treatment initiation and follow up Revista de Neurologia 55(Suppl 1): S21-S24
Ugazio, A.G.; Duse, M.; Plebani, A.; Notarangelo, L.D.; Burgio, G.R. 1983: Subcutaneous infusion of gamma globulins in the management of agammaglobulinemic patients Birth Defects Original Article Series 19(3): 213-215
Saha, M.T.; Huupponen, T.; Komulainen, J. 1998: Continuous subcutaneous insulin infusion as a treatment of diabetes in children and adolescents Duodecim; Laaketieteellinen Aikakauskirja 114(14): 1410-1415
Dryáková, M. 1996: The conditions, indications and contraindications of treatment of diabetes using subcutaneous infusion of insulin Casopis Lekaru Ceskych 135(2): 43-49
Yebra, M.; Barrios, Y.; Rincón, J.; Sanjuan, I.; Díaz-Espada, F. 2002: Severe cutaneous vasculitis following intravenous infusion of gammaglobulin in a patient with type Ii mixed cryoglobulinemia Clinical and Experimental Rheumatology 20(2): 225-227
Giménez de Béjar, V.ón.; Carballo-Cordero, M. 2012: Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications Revista de Neurologia 55(Suppl 1): S25-S29
Leblanc, H.; Obadia, G.; Passa, P. 1986: Reduction of hypoglycemia in 10 diabetic patients treated with continuous subcutaneous infusion of insulin Presse Medicale 15(10): 463-466
Pickup, J.C. 1984: Continuous subcutaneous insulin infusion as a treatment option: a perspective after seven years of research applications Diabetic medicine: a journal of the British Diabetic Association 1(1): 27-32
Costa Gil, J.E.; Galloway, J.A.; Wentworth, S.M. 1982: Treatment of diabetics with the Auto-syringe pump for the continuous infusion of insulin by the subcutaneous route Revista Clinica Espanola 164(6): 377-381
Liliemark, J.O.; Gahrton, G.; Paul, C.Y.; Peterson, C.O. 1987: Ara-C in plasma and ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of ara-C in patients with acute nonlymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1: 167-171
Iorio, A.; Federici, M.Orsini.; Mourvaki, E.; Ferolla, P.; Piroddi, M.; Stabile, A.; Timi, A.; Celleno, R.; Benedetti, M.Massi. 2007: Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients Thrombosis and Haemostasis 98(3): 635-641
Thomakos, P.; Panagopoulos, G.; Kepaptsoglou, O.; Zoupas, C.; Mitrakou, A. 2018: Which Factors May Affect the Quality of Life in Patients with Type 1 Diabetes Mellitus Using the Medtronic Veo Continuous Subcutaneous Insulin Infusion Pump? Georgian Medical News 2018(277): 61-67
Dominguez Álvarez, R.ío.; Calderón Carrasco, J.; García Colchero, F.; Postigo Mota, S.; Alburquerque Medina, E. 2015: Pharmacological Treatment in Palliative Care. Drug Administration Route, Continuous Subcutaneous Infusion, Adverse Side Effects, Symptom Management Revista de Enfermeria 38(1): 54-58; 61-65
Bouhanick, B.; Biquard, F.; Hadjadj, S.; Roques, M.A. 2000: Does treatment with antenatal glucocorticoids for the risk of premature delivery contribute to ketoacidosis in pregnant women with diabetes who receive continuous subcutaneous insulin infusion (CSII)? Archives of Internal Medicine 160(2): 242-243
Van Ballegooie, E.; Reitsma, W.D.; Sluiter, W.J.; Doorenbos, H. 1984: Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes Netherlands Journal of Medicine 27(5): 185-192
Ypenburg, C.; Verwey, H.F.; van der Wall, E.E. 2007: Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner Nederlands Tijdschrift Voor Geneeskunde 151(44): 2426-2428